BTCC
/
BTCC Square
/
Global Cryptocurrency
/
Coinbase CEO’s Biotech Firm Secures $130M to Combat Aging Through AI and Genomics
Coinbase CEO’s Biotech Firm Secures $130M to Combat Aging Through AI and Genomics
17
1
NewLimit, a biotech startup co-founded by Coinbase CEO Brian Armstrong, has raised $130 million in a Series B funding round. The firm aims to extend healthy human lifespan using AI-driven cell reprogramming techniques. Kleiner Perkins led the investment, with participation from Founders Fund, Dimension Capital, and notable angel investors including Elad Gil and Stripe co-founder Patrick Collison.
The funding brings NewLimit’s total capital to over $170 million, positioning it among a growing cohort of longevity ventures backed by tech billionaires. The sector has gained traction as advances in genomics and machine learning converge to tackle age-related diseases.
By:
Previous
E-Commerce Firm Xcotton Co. Faces Class Action Over Unlicensed Warranty Services
Next
Senate Committee Investigates Trump’s Crypto Connections for Potential Conflicts of Interest
